John C. Lieske, MD

Mayo Clinic

Dr. Lieske is a nephrologist at Mayo Clinic in Rochester, Minnesota, and a Professor of Medicine at Mayo Clinic College of Medicine. Dr. Lieske has a long-standing interest in urinary stone disease and urinary proteomics and has over the last decade completed multiple clinical trials evaluating various potential treatment strategies for urinary stone patients including those with primary and enteric hyperoxaluria. Dr. Lieske earned his MD from the University of Chicago, and then completed his Internal Medicine residency at Emory University followed by a clinical and research nephrology fellowship at the University of Chicago. In addition to his active kidney stone practice Dr. Lieske is medical director of the Renal Testing laboratory at Mayo Clinic that coordinates all kidney related testing, including those related to the diagnosis and treatment of kidney stone patients. Currently Dr. Lieske serves as director for the Rare Kidney Stone Consortium and site PI for the Unites States Urinary Stone Disease Network recruiting site at Mayo Clinic.

Disclosure information not submitted.

Presentation(s):

• PD05-03: Efficacy and Safety of Lumasiran in Patients With Primary Hyperoxaluria Type 1: 24-Month Analysis of the ILLUMINATE-A Trial

  Friday, May 13, 2022
  9:50 AM – 10:00 AM

• 021IC - American Urological Association Surgical and Medical Management of Stone Disease Guidelines: Update and Complex Cases

  Friday, May 13, 2022
  4:00 PM – 6:00 PM

• PD50-07: Defining Stone Passage in a Clinical Trial: Adjudication in the Prevention of Urinary Stones with Hydration (PUSH) Study

  Sunday, May 15, 2022
  4:30 PM – 4:40 PM